MCH ADVISORY RESEARCH
Health Care

Health Care Supplies

7 companies under coverage.

Coverage

Health Care Supplies


Equity Research

Dentsply Sirona Inc (XRAY)

BUY. 12-month probability-weighted target $14 (+24% vs spot). Gross Margin explains 67% of Monte Carlo outcome variance.

XRAYEquity ResearchMonte Carlo
25 August 2026Rating: BUY
Equity Research

West Pharmaceutical Services Inc (WST)

HOLD. 12-month probability-weighted target $343 (-3% vs spot). P/E Multiple explains 62% of Monte Carlo outcome variance.

WSTEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Envista Holdings Corp (NVST)

HOLD. 12-month probability-weighted target $26 (-4% vs spot). Gross Margin explains 67% of Monte Carlo outcome variance.

NVSTEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Lantheus Holdings Inc (LNTH)

HOLD. 12-month probability-weighted target $104 (+3% vs spot). P/E Multiple explains 70% of Monte Carlo outcome variance.

LNTHEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Haemonetics Corporation (HAE)

SELL. 12-month probability-weighted target $79 (-27% vs spot). P/E Multiple explains 59% of Monte Carlo outcome variance.

HAEEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

The Cooper Companies, Inc (COO)

HOLD. 12-month probability-weighted target $70 (-8% vs spot). P/E Multiple explains 67% of Monte Carlo outcome variance.

COOEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Align Technology Inc (ALGN)

HOLD. 12-month probability-weighted target $169 (+6% vs spot). P/E Multiple explains 64% of Monte Carlo outcome variance.

ALGNEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
MCH ADVISORY SERVICES · All research · Not investment advicemchadvisoryservices.com ↗ · Research Standard v4 (decision-level) · Research OS ros-1.19.0 · US-listed · UK English